Advertisement
340B 'mega-guidance' may narrow drug discounts

340B 'mega-guidance' may narrow drug discounts

By Modern Healthcare  |  August 28, 2015

Federal regulators released long-awaited “mega-guidance” for the 340B Drug Pricing Program to clarify who is eligible to participate. It comes amid mounting criticism that the program has become overly broad with insufficient oversight.

With Nevada co-op closing, are more to come?

By Modern Healthcare  |  August 28, 2015

Nevada Health CO-OP is shutting down by Jan. 1, the not-for-profit health plan announced Wednesday. It is now the third co-op to fold, and data suggest it's possible other co-ops may follow suit.

States taking the lead in laws to curb drug costs

By Modern Healthcare  |  August 28, 2015

Massachusetts has introduced legislation to require pricing transparency and allow some price caps. Six other states are following, all while Congress acknowledges that there's a problem but has yet to do anything about it.

Will biosimilars naming plan promote more competitive drug pricing?

By Modern Healthcare  |  August 28, 2015

Biosimilar drugs will carry a four-letter suffix on the nonproprietary names they share with brand-name biologic drugs, the FDA announced Thursday. It's a move that could determine how lower-cost alternatives compete against their original counterparts.

Amgen wins approval for second biotech cholesterol drug

By Modern Healthcare  |  August 28, 2015

Amgen has won approval for the second medicine in a new class of biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.

340B 'mega-guidance' may narrow drug discounts

340B 'mega-guidance' may narrow drug discounts

By Steven Ross Johnson  |  August 27, 2015

Federal regulators released long-awaited “mega-guidance” for the 340B Drug Pricing Program to clarify who is eligible to participate. It comes amid mounting criticism that the program has become overly broad with insufficient oversight.

CMS sends Medicaid outpatient drug rule to OMB

By Virgil Dickson  |  August 27, 2015

The CMS has completed work on a long-awaited rule overhauling the way prescription drugs are purchased for Medicaid beneficiaries. The regulation has been submitted to the Office of Management and Budget for review.

Cleveland Clinic Rehabilitation Hospital names CEO

By Michael Sandler  |  August 27, 2015

Cleveland Clinic Rehabilitation Hospital on Thursday named Hossam “Sam” Bayoumy its Chief Executive Officer. Bayoumy, 43, will lead the 60-bed acute inpatient rehabilitation hospital after its slated December opening. The facility is a joint venture between Select Medical and Cleveland...

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.